Aurisco Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042S4
CNY
25.05
0.05 (0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Negative results in Sep 25

  • INTEREST(HY) At CNY 17.36 MM has Grown at 210.44%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 1.1 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.24 times
2

With ROE of 16.35%, it has a fair valuation with a 3.73 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 10,491 Million (Mid Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.09%

stock-summary
Debt Equity

-0.00

stock-summary
Return on Equity

16.51%

stock-summary
Price to Book

4.13

Revenue and Profits:
Net Sales:
415 Million
(Quarterly Results - Sep 2025)
Net Profit:
119 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.81%
0%
4.81%
6 Months
12.38%
0%
12.38%
1 Year
20.26%
0%
20.26%
2 Years
14.86%
0%
14.86%
3 Years
-5.04%
0%
-5.04%
4 Years
-0.04%
0%
-0.04%
5 Years
70.99%
0%
70.99%

Aurisco Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
20.69%
EBIT Growth (5y)
27.99%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.51
Tax Ratio
12.85%
Dividend Payout Ratio
32.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.19%
ROE (avg)
13.03%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.73
EV to EBIT
20.12
EV to EBITDA
16.51
EV to Capital Employed
3.70
EV to Sales
5.85
PEG Ratio
5.00
Dividend Yield
1.26%
ROCE (Latest)
18.39%
ROE (Latest)
16.35%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 16.05% vs -3.30% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 24.58% vs -29.95% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "415.10",
          "val2": "357.70",
          "chgp": "16.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "140.70",
          "val2": "136.20",
          "chgp": "3.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.80",
          "val2": "5.20",
          "chgp": "69.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "0.70",
          "chgp": "171.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "118.60",
          "val2": "95.20",
          "chgp": "24.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "339.00%",
          "val2": "316.90%",
          "chgp": "2.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.93% vs 25.33% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.73% vs 38.79% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,471.20",
          "val2": "1,258.20",
          "chgp": "16.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "474.20",
          "val2": "357.90",
          "chgp": "32.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.80",
          "val2": "3.60",
          "chgp": "366.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "354.80",
          "val2": "289.10",
          "chgp": "22.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "261.00%",
          "val2": "219.50%",
          "chgp": "4.15%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
415.10
357.70
16.05%
Operating Profit (PBDIT) excl Other Income
140.70
136.20
3.30%
Interest
8.80
5.20
69.23%
Exceptional Items
1.90
0.70
171.43%
Consolidate Net Profit
118.60
95.20
24.58%
Operating Profit Margin (Excl OI)
339.00%
316.90%
2.21%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 16.05% vs -3.30% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 24.58% vs -29.95% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,471.20
1,258.20
16.93%
Operating Profit (PBDIT) excl Other Income
474.20
357.90
32.50%
Interest
16.80
3.60
366.67%
Exceptional Items
2.30
0.00
Consolidate Net Profit
354.80
289.10
22.73%
Operating Profit Margin (Excl OI)
261.00%
219.50%
4.15%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 16.93% vs 25.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.73% vs 38.79% in Dec 2023

stock-summaryCompany CV
About Aurisco Pharmaceutical Co., Ltd. stock-summary
stock-summary
Aurisco Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available